ZyVet? Animal Health launches first FDA-approved generic of phenylpropanolamine hydrochloride tablets

For treatment of urinary incontinence in dogs

ZyVet? Animal Health, a leader in affordable generic pharmaceuticals for animals, a wholly owned subsidiary of Zydus Pharmaceuticals (USA) Inc., itself a wholly owned subsidiary of Zydus Lifesciences, a global innovation led healthcare company, has released the first FDA-approved generic of phenylpropanolamine hydrochloride tablets, a trusted treatment for managing urinary incontinence in dogs. This latest product underscores ZyVet's mission to bring trusted, high-quality, and cost-effective therapies to veterinary professionals across the United States.

Phenylpropanolamine hydrochloride is commonly prescribed to treat urinary incontinence in dogs due to urethral sphincter hypotonus. Often seen in spayed females and aging dogs, urethral sphincter hypotonus can lead to frustrating and embarrassing accidents. ZyVet's generic provides dependable symptom relief while supporting stronger long-term client compliance. Available in multiple strengths to support precise dosing, the product is designed with the needs of both veterinary teams and pet owners in mind.

Powered by Capital Market - Live News